Core Viewpoint - Quantitative investment products have become a significant choice for investors seeking excess returns amid market fluctuations, particularly among large private equity firms with mature strategies and technical capabilities [3] Group 1: Performance Metrics - The average excess return for quantitative products under large private equity firms (over 10 billion) is 13.90% for 2025, with an excess win rate of 61.01% [4] - The average return for quantitative products across different asset sizes shows that those over 100 billion have the highest average return of 38.60% [4] - The overall average excess return across all private equity products is 11.33%, with an average excess win rate of 56.20% [4] Group 2: Top Performers in Different Indices - In the CSI 300 index enhancement category, Mingxuan Investment leads with an excess win rate of 66.25% and an average return of 30.05% for 2025 [5] - The top products in the CSI 500 index enhancement category include Wanyan Asset with a leading excess win rate of 66.12% and an average return of 50.84% [8] - For the CSI 1000 index enhancement, Micron Bo Yi leads with an impressive excess win rate of 72.71% and an average return of 55.96% [11] Group 3: Notable Companies and Strategies - Mingxuan Investment, established in 2014, has a strong team with backgrounds from top universities and has successfully applied AI technology in financial markets [7] - Wanyan Asset, founded in 2015, focuses on high liquidity assets and has made significant investments in AI to enhance market prediction accuracy [10] - Micron Bo Yi, also established in 2015, utilizes a data-driven approach and has a team of experts from prestigious institutions, focusing on extracting effective information from vast data [13] Group 4: Other Noteworthy Products - In the category of other index enhancements, Montrose Investment leads with a high excess win rate of 65.83% and an average return of 46.44% [14] - Square and Investment's product in the CSI 2000 index enhancement category has shown a strong performance with an excess win rate of 43 out of 53 weeks in 2025 [16]

Core Viewpoint - In 2025, the Chinese market showed significant growth, with major stock markets rising sharply and structural opportunities in various sectors, particularly in technology growth stocks, which drove the ChiNext Index up nearly 50% [2] Market Performance Summary - The performance of major indices in 2025 included: - Shanghai Composite Index: 18.41% increase in January, with a total of 8.74% in September [3] - ChiNext Index: 49.57% increase in January, but a notable drop of over 7% in April due to external shocks [3] - Shenzhen Component Index: 29.87% increase in January, with fluctuations throughout the year [3] - Hang Seng Index: 27.77% increase in January, with varying monthly performance [3] Private Fund Performance Summary - In the private fund market, 2025 saw a total of 5,139 products with data showing an average cumulative return of 31.83%, with only 229 products (4.46%) achieving positive returns for 12 consecutive months [4] - Among the top-performing private funds, 1,006 products had performance data, with 88 (8.75%) achieving positive returns for 12 consecutive months [4] - The top 20 products in the private fund sector had a threshold for cumulative returns, with a majority being quantitative long products [4] Notable Products and Managers - The "Square and Peak Zhongzheng 2000 Index Enhanced 21" managed by Square and Investment achieved significant returns, with the highest monthly return in August [7] - The "Yizu Qinggui Li Dong" managed by Yizu Investment topped the list among private funds under 5 billion, with substantial returns in March and December [10] - The "Hua Nian Progress 2A" managed by Xue Yuxin ranked fifth, showcasing strong performance [11] Excess Return Analysis - In 2025, 802 quantitative long products had data on excess returns, with only 30 (3.74%) achieving positive excess returns for 12 consecutive months [13] - The top 10 products in terms of cumulative excess returns were managed by firms such as Jintong Investment and Ming Stone Fund [14][16]

Core Insights - Deepseek has emerged in the AI sector, revitalizing quantitative investment, particularly in a market favoring small and mid-cap stocks [1] - Despite a general adjustment in the A-share market in November, many quantitative products from large private equity firms achieved historical highs, with over 80% being quantitative products [1] - The average return for 1,833 quantitative products this year is 26.98%, with an excess return of 11.41% [2] Quantitative Investment Performance - The top-performing quantitative long strategy products (833 in total) achieved returns of 40.34% and excess returns of 17.25% [2] - Other quantitative strategies include: - Quantitative CTA: 379 products with average returns of 16.32% and excess returns of 13.76% [2] - Stock market neutral: 200 products with average returns of 9.37% and excess returns of -4.93% [2] - Composite strategy: 154 products with average returns of 23.85% and excess returns of 7.61% [2] - Options strategy: 56 products with average returns of 11.04% and excess returns of 8.60% [2] Top Quantitative Stock Selection Products - As of November 2025, there are 331 quantitative stock selection products with an average return of 39.40% and an average excess return of 19.14% [3] - The top three products in excess returns are from Zhuhai Zhengfeng Private Equity, Shui Zhuo Quan Asset, and Jiuming Investment [3] Performance of Specific Strategies - The "CSI 500 Index Enhanced" products have 197 products with average returns of 40.17% and excess returns of 14.14% [8] - The top three products in this category are from Zhaoxin Private Fund, Guobiao Asset, and Zhaoyue Private Fund [8] - The "CSI 1000 Index Enhanced" products have 167 products with average returns of 44.68% and excess returns of 17.53% [14] - The top three products in this category are from Jintong Investment, Luxiu Investment, and Mengxi Investment [14] Notable Fund Managers and Products - The "Hanhong Ansheng Progress No. 1 B Class" product managed by Hanhong Investment has outstanding performance with excess returns of ***% [6] - The "Longqi Technology Innovation Selected No. 1 C Class" product managed by Zhu Xiaokang has also shown impressive returns [7] - The "Zhaoxin CSI 500 Index Enhanced No. 1 A Class" managed by Tang Yue and Hu Chenhang has the highest excess returns in its category [12]

Core Viewpoint - The article highlights the emergence of Mengxi Investment as a new entrant in the billion-yuan quantitative private equity sector, emphasizing its strong research, risk control, and strategy advantages in a favorable market environment [2]. Group 1: Company Overview - Mengxi Investment, established in 2016, is one of the pioneers in the domestic quantitative industry, leveraging robust data mining, statistical analysis, and software development capabilities to create a comprehensive quantitative asset management platform [2]. - The company has a research team of over 60 members with diverse academic backgrounds from top global universities in physics, mathematics, and finance [2]. - Mengxi Investment invests tens of millions annually in alternative data and IT infrastructure, maintaining a powerful computing cluster and developing low-latency trading algorithms capable of achieving sub-millisecond delays [2]. Group 2: Product Performance - As of November 21, 2025, Mengxi Investment has 10 products that have shown performance this year, all managed by Li Xiang, with an average return of ***% [3]. - Among these, eight are quantitative long products, achieving an average excess return of ***% this year [3]. Group 3: Investment Strategy - Mengxi Investment's strategy focuses on low-latency trading, which requires significant long-term investment in infrastructure, data mining, hardware upgrades, and strategy iteration, creating a high barrier to entry [7]. - The company emphasizes a diversified approach to its index enhancement products, which helps capture excess returns across various market conditions while maintaining strict risk control [9]. - The "Mengxi CSI 1000 Index Quantitative 5th Class A Share" product has ranked first in excess returns among billion-yuan private equity products this year, demonstrating resilience in different market environments [10][12]. Group 4: Risk Management - Mengxi Investment employs a multi-layered risk management strategy, focusing on portfolio construction, position management, execution, and governance to ensure long-term stable returns for clients [16]. - The firm does not adjust strategies based on single popular sectors but utilizes a comprehensive market-wide approach to determine final portfolio holdings [18]. Group 5: Technological Advancements - In 2019, Mengxi Investment began using AI to assist in research and development, and in early 2025, it established an AI Lab to enhance its investment research capabilities through deep learning [20]. - The company aims to optimize strategy development efficiency and extend the lifecycle of its strategies by leveraging technology [21].

Core Viewpoint - The A-share market showed strong performance in August, with major indices rising significantly, yet the excess returns of stock strategy private equity products were disappointing, marking the worst monthly performance of the year [1][2]. Group 1: Market Performance - In August, the Shanghai Composite Index rose by 7.97%, the Shenzhen Component Index increased by 15.32%, and the ChiNext Index surged over 24% [1]. - Despite the strong market, the average excess return of 3,122 stock strategy private equity products was -1.97%, the worst monthly performance this year [1]. Group 2: Quantitative vs. Subjective Strategies - Quantitative private equity products experienced a notable decline, with an average excess return of -3.94% in August, while subjective private equity products had an average excess return of -1.00% [1]. - The significant decline in quantitative products is attributed to a reversal in style, particularly the outperformance of large-cap stocks over small-cap stocks, and severe sector differentiation due to rapid growth in financing scale [1][2]. Group 3: Consistent Performers - As of August 2025, only 95 stock strategy private equity products achieved positive excess returns for eight consecutive months, representing about 3% of the total [2]. - Among private equity firms with over 10 billion in assets, 46 products achieved positive excess returns for eight consecutive months, all of which were quantitative products, with an average excess return of 0.63% in August and 17.91% year-to-date [3]. Group 4: Top Performers by Asset Size - In the 20-100 billion category, 14 products achieved positive excess returns for eight consecutive months, with an average excess return of 1.83% in August and 22.48% year-to-date [7]. - The top three products in this category were "New Thinking Multi-Strategy 3", "Pansong Micro-Cap Index Enhanced 1", and "Giraffe 7", with year-to-date excess returns of ***% [11]. Group 5: Small and Emerging Firms - In the 5-20 billion category, 13 products achieved positive excess returns for eight consecutive months, with an average excess return of 5.34% in August and 57.58% year-to-date [13]. - The leading product in the 0-5 billion category was "Zijin Yunsong", achieving a year-to-date excess return of ***% [18].

Core Viewpoint - The article highlights the strong performance of quantitative long products from billion-level private equity firms in the A-share market since August, with average returns significantly increasing for various strategies [1]. Summary by Category Quantitative Stock Selection Products - As of August 22, 2025, there are 234 quantitative long products under billion-level private equity firms, with an average return of ***% this year [1]. - The top-performing products in the quantitative stock selection category have shown an average return close to ***% [1]. Top 10 Products in the "CSI 1000 Index Enhancement" Category - The article lists the top 10 products in the "CSI 1000 Index Enhancement" category, with the leading product being "Mengxi CSI 1000 Quantitative No. 5 A-Class" managed by Li Ji from Mengxi Investment [4]. - Other notable products include "Qianyan Liuhe No. 6 1000 Enhancement B-Class" and "Mingfa Quantitative Small Cap Enhancement No. 1 B-Class" [4]. Top 10 Products in the "CSI 300 Index Enhancement" Category - The leading product in the "CSI 300 Index Enhancement" category is "Jiu Zhang Huan Fang CSI 300 Quantitative Multi-Strategy No. 1," managed by Xu Jin from Ningbo Huan Fang Quantitative [7]. - Other top products include "Mingxuan Stable Growth No. 2" and "Zhengding CSI 300 Index Enhancement No. 1 B-Class" [7]. Top 10 Products in the "CSI 500 Index Enhancement" Category - The article provides a list of the top products in the "CSI 500 Index Enhancement" category, highlighting the competitive performance of various funds [10]. Top 10 Products in the "Other Index Enhancement" Category - The article also details the top products in the "Other Index Enhancement" category, showcasing the diversity of strategies employed by different private equity firms [14]. Notable Firms and Strategies - Mengxi Investment has established a strong reputation with its quantitative strategies, leveraging a team with significant academic backgrounds in quantitative finance [16]. - Ningbo Huan Fang Quantitative has also gained recognition for its high returns, particularly in the CSI 300 Index Enhancement category [19].